Merck & Co. (MRK)
(Delayed Data from NYSE)
$105.39 USD
-0.45 (-0.43%)
Updated Sep 26, 2023 04:00 PM ET
After-Market: $105.39 0.00 (0.00%) 7:58 PM ET
3-Hold of 5 3
C Value D Growth F Momentum D VGM
- YR Estimate
- 12/31/2022
- 12/31/2021
- 12/31/2020
- 12/31/2019
- 12/31/2018
- Revenue - Line of Business (LOBR)
- Sales: Keytruda
- 20,937.00
- 17,186.00
- 14,380.00
- 11,084.00
- 7,171.00
- Revenue - Line of Business (LOBR)
- Sales: Alliance Revenue: Lynparza
- 1,116.00
- 989.00
- 725.00
- 444.00
- 187.00
- Revenue - Line of Business (LOBR)
- Sales: Alliance revenue: Lenvima
- 876.00
- 704.00
- 580.00
- 404.00
- 149.00
- Revenue - Line of Business (LOBR)
- Sales: Oncology: Alliance revenue: Reblozyl
- 166.00
- 17.00
- --
- --
- --
- Revenue - Line of Business (LOBR)
- Sales: Gardasil
- 6,897.00
- 5,673.00
- 3,938.00
- 3,737.00
- 3,151.00
- Revenue - Line of Business (LOBR)
- Sales: ProQuar/M-M-R II/Varivax
- 2,241.00
- 2,135.00
- 1,878.00
- 2,275.00
- 1,798.00
- Revenue - Line of Business (LOBR)
- Sales: RotaTeq
- 783.00
- 807.00
- 797.00
- 791.00
- 728.00
- Revenue - Line of Business (LOBR)
- Sales: Pneumovax
- 602.00
- 893.00
- 1,087.00
- 926.00
- 907.00
- Revenue - Line of Business (LOBR)
- Sales: Vaccines: Vaqta
- 173.00
- 179.00
- 170.00
- 238.00
- 239.00
- Revenue - Line of Business (LOBR)
- Total Vaccine [$M]
- 10,696.00
- 10,132.00
- 8,257.00
- 8,368.00
- 7,262.00
- Revenue - Line of Business (LOBR)
- Sales: Remicade
- 207.00
- 299.00
- 330.00
- 411.00
- 582.00
- Revenue - Line of Business (LOBR)
- Sales: Simponi
- 706.00
- 825.00
- 838.00
- 830.00
- 893.00
- Revenue - Line of Business (LOBR)
- Segment revenues: Animal health
- 5,550.00
- 5,568.00
- 4,703.00
- 4,393.00
- 4,212.00
- Revenue - Line of Business (LOBR)
- Sales: Bridion
- 1,685.00
- 1,532.00
- 1,198.00
- 1,131.00
- 917.00
- Revenue - Line of Business (LOBR)
- Sales: Hospital Acute Care: Prevymis
- 428.00
- 370.00
- 281.00
- 165.00
- --
- Revenue - Line of Business (LOBR)
- Sales: Cardiovascular: Adempas
- 238.00
- 252.00
- 220.00
- 215.00
- 329.00
- Revenue - Line of Business (LOBR)
- Sales: Isentress
- 633.00
- 769.00
- 857.00
- 975.00
- 1,140.00
- Revenue - Line of Business (LOBR)
- Other Revenues
- 1,728.00
- 382.00
- 182.00
- 521.00
- 143.00
- Revenue - Line of Business (LOBR)
- Segment revenues: Pharmaceutical
- 52,005.00
- 42,754.00
- 36,610.00
- 41,751.00
- 37,689.00
- Revenue - Line of Business (LOBR)
- Sales: Hospital Acute Care: Dificid
- 263.00
- 175.00
- --
- --
- --
- Revenue - Line of Business (LOBR)
- Sales: Virology: Lagevrio
- 5,684.00
- 952.00
- --
- --
- --
- Revenue - Line of Business (LOBR)
- Sales: Cardiovascular: Alliance revenue - Adempas
- 341.00
- 342.00
- 281.00
- 204.00
- --
- Revenue - Line of Business (LOBR)
- Sales: Hospital Acute Care: Zerbaxa
- 169.00
- -1.00
- 130.00
- 121.00
- --
- Revenue - Line of Business (LOBR)
- Sales: Animal Health: Companion Animal
- 2,250.00
- 2,273.00
- 1,764.00
- 1,609.00
- 1,582.00
- Revenue - Line of Business (LOBR)
- Sales: Animal Health: Livestock
- 3,300.00
- 3,295.00
- 2,939.00
- 2,784.00
- 2,630.00
- Revenue - Line of Business (LOBR)
- Sales: Neuroscience: Belsomra- International
- 179.00
- 241.00
- 247.00
- 214.00
- 164.00
- Revenue - Line of Business (LOBR)
- Sales: Neuroscience: Belsomra- US
- 79.00
- 78.00
- 81.00
- 92.00
- 96.00
- Revenue - Line of Business (LOBR)
- Sales: Diabetes: Janumet
- 1,700.00
- 1,964.00
- 1,971.00
- 2,041.00
- 2,228.00
- Revenue - Line of Business (LOBR)
- Sales: Diabetes: Januvia
- 2,813.00
- 3,324.00
- 3,306.00
- 3,482.00
- 3,686.00
- Revenue - Line of Business (LOBR)
- Sales: Primaxin
- 239.00
- 259.00
- 251.00
- 273.00
- 265.00
- Revenue - Line of Business (LOBR)
- Sales: Diabetes: Other pharmaceutical
- 2,249.00
- 2,118.00
- 2,312.00
- 696.00
- 4,705.00
- Revenue - Line of Business (LOBR)
- Sales: Noxafil
- 238.00
- 259.00
- 329.00
- 662.00
- 742.00
- Revenue - Geographic (GEOR)
- Sales: Keytruda- U.S
- 12,686.00
- 9,765.00
- 8,352.00
- 6,305.00
- 4,150.00
- Revenue - Geographic (GEOR)
- Sales: Keytruda-International
- 8,251.00
- 7,421.00
- 6,028.00
- 4,779.00
- 3,021.00
- Revenue - Geographic (GEOR)
- Sales: Oncology: Alliance revenue: Lynparza- US
- 584.00
- 515.00
- 417.00
- 269.00
- 127.00
- Revenue - Geographic (GEOR)
- Sales: Oncology: Alliance revenue: Lynparza- International
- 532.00
- 473.00
- 308.00
- 176.00
- 61.00
- Revenue - Geographic (GEOR)
- Sales: Oncology: Alliance revenue: Lenvima - U.S
- 579.00
- 417.00
- 359.00
- 239.00
- 95.00
- Revenue - Geographic (GEOR)
- Sales: Oncology: Alliance revenue: Lenvima - International
- 297.00
- 287.00
- 220.00
- 165.00
- 54.00
- Revenue - Geographic (GEOR)
- Sales: Oncology: Alliance revenue: Reblozyl- U.S
- 123.00
- 0.00
- --
- --
- --
- Revenue - Geographic (GEOR)
- Sales: Oncology: Alliance revenue: Reblozyl- International
- 43.00
- 17.00
- --
- --
- --
- Revenue - Geographic (GEOR)
- Sales: Gardasil - U.S
- 2,065.00
- 1,881.00
- 1,755.00
- 1,831.00
- 1,873.00
- Revenue - Geographic (GEOR)
- Sales: Vaccines: Gardasil-International
- 4,832.00
- 3,792.00
- 2,184.00
- 1,905.00
- 1,279.00
- Revenue - Geographic (GEOR)
- Sales: Hospital Acute Care: Primaxin-International
- 238.00
- 258.00
- 248.00
- 271.00
- 258.00
- Revenue - Geographic (GEOR)
- Sales: Vaccines: ProQuar/M-M-R II-International
- 518.00
- 506.00
- 500.00
- 592.00
- 368.00
- Revenue - Geographic (GEOR)
- Sales: Vaccines: Rotateq-International
- 275.00
- 334.00
- 311.00
- 284.00
- 232.00
- Revenue - Geographic (GEOR)
- Sales: Infectious Disease: Noxafil US
- 51.00
- 60.00
- 42.00
- 282.00
- 353.00
- Revenue - Geographic (GEOR)
- Sales: Infectious Disease: Noxafil International
- 187.00
- 199.00
- 287.00
- 380.00
- 389.00
- Revenue - Geographic (GEOR)
- Sales: Primaxin- U.S
- 1.00
- 2.00
- 2.00
- 2.00
- 7.00
- Revenue - Geographic (GEOR)
- Sales: Vaccines: ProQuad, M-M-R II and Varivax - U.S
- 1,724.00
- 1,629.00
- 1,378.00
- 1,683.00
- 1,430.00
- Revenue - Geographic (GEOR)
- Sales: Vaccines: RotaTeq - U.S
- 508.00
- 473.00
- 486.00
- 506.00
- 496.00
- Revenue - Geographic (GEOR)
- Sales: Vaccines: Pneumovax - U.S
- 346.00
- 547.00
- 727.00
- 679.00
- 627.00
- Revenue - Geographic (GEOR)
- Sales: Vaccines: Pneumovax - International
- 256.00
- 346.00
- 359.00
- 247.00
- 281.00
- Revenue - Geographic (GEOR)
- Sales: Virology: Isentress - U.S
- 274.00
- 294.00
- 326.00
- 398.00
- 513.00
- Revenue - Geographic (GEOR)
- Sales: Animal health - U.S
- 1,822.00
- 1,758.00
- 1,484.00
- 1,306.00
- 1,238.00
- Revenue - Geographic (GEOR)
- Sales: Animal health - International
- 3,728.00
- 3,810.00
- 3,219.00
- 3,086.00
- 2,974.00
- Revenue - Geographic (GEOR)
- Sales: Hospital Acute Care: Bridion - International
- 762.00
- 770.00
- 615.00
- 598.00
- 531.00
- Revenue - Geographic (GEOR)
- Sales: Hospital Acute Care: Bridion- U.S
- 922.00
- 762.00
- 583.00
- 533.00
- 386.00
- Revenue - Geographic (GEOR)
- Sales: Diabetes: Januvia- U.S
- 1,248.00
- 1,404.00
- 1,470.00
- 1,724.00
- 1,969.00
- Revenue - Geographic (GEOR)
- Sales: Diabetes: Janumet- U.S
- 355.00
- 367.00
- 477.00
- 589.00
- 811.00
- Revenue - Geographic (GEOR)
- Sales: Cardiovascular: Adempas - International
- 238.00
- 252.00
- 220.00
- 215.00
- 329.00
- Revenue - Geographic (GEOR)
- Sales: Neuroscience: Belsomra
- 258.00
- 318.00
- 327.00
- 306.00
- 260.00
- Revenue - Geographic (GEOR)
- Sales: Animal Health: Livestock- US
- 710.00
- 667.00
- 612.00
- 582.00
- 528.00
- Revenue - Geographic (GEOR)
- Sales: Animal Health: Livestock- International
- 2,590.00
- 2,628.00
- 2,327.00
- 2,201.00
- 2,102.00
- Revenue - Geographic (GEOR)
- Sales: Animal Health: Companion Animal- US
- 1,112.00
- 1,091.00
- 872.00
- 724.00
- 710.00
- Revenue - Geographic (GEOR)
- Sales: Animal Health: Companion Animal- International
- 1,138.00
- 1,182.00
- 892.00
- 885.00
- 872.00
- Revenue - Geographic (GEOR)
- Sales: Vaccines: Vaqta- US
- 95.00
- 100.00
- 103.00
- 130.00
- 127.00
- Revenue - Geographic (GEOR)
- Sales: Vaccines: Vaqta- International
- 78.00
- 79.00
- 67.00
- 108.00
- 112.00
- Revenue - Geographic (GEOR)
- Sales: Hospital Acute Care: Zerbaxa- US
- 89.00
- 4.00
- 74.00
- 63.00
- --
- Revenue - Geographic (GEOR)
- Sales: Hospital Acute Care: Zerbaxa- International
- 79.00
- -5.00
- 56.00
- 58.00
- --
- Revenue - Geographic (GEOR)
- Sales: Cardiovascular: Alliance revenue: Adempas-US
- 329.00
- 312.00
- 259.00
- 194.00
- --
- Revenue - Geographic (GEOR)
- Sales: Cardiovascular: Alliance revenue: Adempas-International
- 12.00
- 30.00
- 22.00
- 10.00
- --
- Revenue - Geographic (GEOR)
- Sales: Hospital Acute Care: Prevymis- US
- 188.00
- 153.00
- 119.00
- 84.00
- --
- Revenue - Geographic (GEOR)
- Sales: Hospital Acute Care: Prevymis- International
- 240.00
- 218.00
- 162.00
- 81.00
- --
- Revenue - Geographic (GEOR)
- Sales: Virology: Lagevrio- International
- 4,161.00
- 320.00
- --
- --
- --
- Revenue - Geographic (GEOR)
- Sales: Hospital Acute Care: Dificid - U.S
- 241.00
- 166.00
- --
- --
- --
- Revenue - Geographic (GEOR)
- Sales: Hospital Acute Care: Dificid - International
- 22.00
- 10.00
- --
- --
- --
- Revenue - Geographic (GEOR)
- Segment revenues: Pharmaceutical - U.S
- 24,989.00
- 20,401.00
- 18,010.00
- --
- --
- Revenue - Geographic (GEOR)
- Segment revenues: Pharmaceutical - International
- 27,016.00
- 22,353.00
- 18,600.00
- --
- --
- Revenue - Geographic (GEOR)
- Sales: Diabetes: Other pharmaceutical - U.S
- 969.00
- 841.00
- 984.00
- --
- --
- Revenue - Geographic (GEOR)
- Sales: Diabetes: Other pharmaceutical: International
- 1,282.00
- 1,275.00
- 1,328.00
- --
- --
- Revenue - Geographic (GEOR)
- Product sales: Other revenues - US
- 395.00
- 266.00
- 71.00
- --
- --
- Revenue - Geographic (GEOR)
- Product sales: Other revenues - International
- 1,333.00
- 116.00
- 111.00
- --
- --
- Revenue - Geographic (GEOR)
- Geographic Revenue: International
- 32,077.00
- 26,279.00
- 21,930.00
- --
- --
- Revenue - Geographic (GEOR)
- Geographic Revenue: United States
- 27,206.00
- 22,425.00
- 19,588.00
- 20,519.00
- 18,212.00
- Revenue - Geographic (GEOR)
- Sales: Virology: Isentress-International
- 359.00
- 474.00
- 326.00
- 576.00
- 627.00
- Revenue - Geographic (GEOR)
- Sales: Diabetes: Janumet-International
- 1,344.00
- 1,597.00
- 1,494.00
- 1,452.00
- 1,417.00
- Revenue - Geographic (GEOR)
- Sales: Diabetes: Januvia-International
- 1,565.00
- 1,920.00
- 1,836.00
- 1,758.00
- 1,718.00